rs376103033
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000135.4(FANCA):c.3157C>T(p.Arg1053Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000948 in 1,614,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000135.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FANCA | NM_000135.4 | c.3157C>T | p.Arg1053Cys | missense_variant | 32/43 | ENST00000389301.8 | NP_000126.2 | |
FANCA | NM_001286167.3 | c.3157C>T | p.Arg1053Cys | missense_variant | 32/43 | NP_001273096.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FANCA | ENST00000389301.8 | c.3157C>T | p.Arg1053Cys | missense_variant | 32/43 | 1 | NM_000135.4 | ENSP00000373952.3 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000215 AC: 54AN: 251440Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135908
GnomAD4 exome AF: 0.0000930 AC: 136AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.0000825 AC XY: 60AN XY: 727246
GnomAD4 genome AF: 0.000112 AC: 17AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 03, 2024 | Variant summary: FANCA c.3157C>T (p.Arg1053Cys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00021 in 251440 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in FANCA causing Fanconi Anemia (0.00021 vs 0.0022), allowing no conclusion about variant significance. c.3157C>T has been reported in the literature in an individual affected with head and neck squamous cell carcinoma (Chandrasekharappa_2017). This report does not provide unequivocal conclusions about association of the variant with Fanconi Anemia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 28678401). ClinVar contains an entry for this variant (Variation ID: 408205). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 02, 2020 | DNA sequence analysis of the FANCA gene demonstrated a sequence change, c.3157C>T, in exon 32 that results in an amino acid change, p.Arg1053Cys. This sequence change does not appear to have been previously described in patients with FANCA-related disorders and has been described in the gnomAD database with a low population frequency of 0.087% in the Latino subpopulation (dbSNP rs376103033). The p.Arg1053Cys change affects a poorly conserved amino acid residue located in a domain of the FANCA protein that is not known to be functional. The p.Arg1053Cys substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to these evidences and the lack of functional studies, the clinical significance of the p.Arg1053Cys change remains unknown at this time. - |
Fanconi anemia complementation group A Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Apr 02, 2021 | FANCA NM_000135.3 exon 32 p.Arg1053Cys (c.3157C>T): This variant has not been reported in the literature but is present in 0.02% (4/15274) of Latino alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/16-89749812-G-A?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:408205). This variant amino acid Cysteine (Cys) is present in several species including multiple primates and other mammals and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Aug 01, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jul 03, 2024 | The FANCA c.3157C>T (p.Arg1053Cys) variant has been reported in the published literature in individuals affected with acute lymphoblastic leukemia (ALL) (PMID: 26580448 (2015)), head and neck squamous cell carcinoma (HNSCC) (PMID: 28678401 (2017)), and ovarian cancer (PMID: 32546565 (2021)). This variant has also been reported in reportedly healthy individuals (PMID: 32546565 (2021)). The frequency of this variant in the general population, 0.00087 (31/35434 chromosomes in Admixed American subpopulation (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is higher than would generally be expected for pathogenic variants in this gene. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant. - |
Fanconi anemia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at